A total of 334 patients with acute exacerbation of chronic bronchitis were treated with either dirithromycin for 5 days (n = 169) or amoxiclav for 7–10 days (n = 165) in an open randomized trial. The efficacy and tolerability of the two drugs were compared. There was no statistically significant difference in outcome between the two treatment arms. Clinical success (cure or improvement) was obtained in 94.5% and 93.1% of patients treated with dirithromycin and amoxiclav, respectively. Adverse events (mostly gastrointestinal) occurred in both groups, but led to discontinuation of treatment (in only seven patients). We conclude that the two drugs are equally efficacious and safe.
BarryALPfallerMAFuchsPCDirithromycin disc susceptibility tests: interpretative criteria and quality control parameters. J Antimicrob Chemother1993; 31 (Suppl C): 27–38.
2.
FernandesPBHardyDJ Comparative in vitro potencies of 9 new macrolides. Drugs Exp Clin Res1988; 14: 445–451.
3.
HardyDJHenseyDM Comparative in vitro activities of new 14-, 15-, 16-membered macrolides. AAC1988; 32: 1710–1719.
4.
BrogdenRPetersDDirithromycin: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs1994; 48: 599–616.
5.
MazzeiTMiniENovelliAChemistry and mode of action of macrolides. J Antimicrob Chemother1993; 31 (Suppl C): 1–9.
6.
KirstHASidesGDNew directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. AAC1989; 33: 1419–1422.
7.
SidesGDCerimeleBJBlackHRPharmacokinetics of dirithromycin. J Antimicrob Chemother1993; 31 (Suppl C): 65–74.
8.
Bergogne-BérézinETissue distribution of dirithromycin: comparison with erythromycin. J Antimicrob Chemother1993; 31 (Suppl C): 77–88.
9.
CazzolaMTufanoMAPolverinoMPulmonary penetration of dirithromycin in chronic bronchitis. In: 6th European Congress of Clinical Microbiology and Infectious Disease. Seville 1993: Abstract 320.
10.
RouveixBLiaison des macrolides aux cytochromes P450 et interactions médicamenteuses: le cas de la dirithromycine. Lettre de 1'Infectiologue, Numéro spécial, janvier 1994: 38.
11.
GaillatJA multicenter study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of chronic bronchitis. J Antimicrob Chemother1993; 31 (Suppl C): 139–154.
12.
SidesGDClinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis. J Antimicrob Chemother1993; 31 (Suppl C): 131–138.
13.
JacobsonKClinical efficacy of dirithromycin in pneumonia. J Antimicrob Chemother1993; 31 (Suppl C): 121–130.
AnthonisenNRAntibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med1987; 106: 196–204.
16.
MechanicDThe concept of illness behaviour. J Chron Dis1961; 15: 189–194.
17.
HosieJQuinnPSmitsA comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis. J Antimicrob Chemother1995; 36: 173–183.
18.
LeroyerCBoussacJLodeHA comparison of 5 days of dirithromycin and 7 days of roxithromycin in acute bacterial exacerbation of chronic bronchitis. Immunol and Infect Diseases1995; 5: 149–155.
